Yaqi Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yaqi Zhou has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Jiaheng Dong
School of Basic Medical Sciences, Henan University, Kaifeng, China
2 shared publications- Lei Zhang
School of Basic Medical Sciences, Henan University, Kaifeng, China
2 shared publications - Changjiang Qin
Department of General Surgery, The Second Affiliated Hospital of Henan University (Huaihe Hospital), Henan University, Kaifeng, China
1 shared publication Chenyao Li
School of Basic Medical Sciences, Henan University, Kaifeng, China
1 shared publicationJiale Zhang
School of Basic Medical Sciences, Henan University, Kaifeng, China
1 shared publicationKunhou Yao
Department of General Surgery, Huaihe Hospital of Henan University, Kaifeng, China
1 shared publication
Latest Publications
- Open Access
- 29 April 2025
- Published by Springer Nature in Cell Death Discovery
- Vol. 11 (1) , 1-11
Exploring necroptosis: mechanistic analysis and antitumor potential of nanomaterials
Necroptosis, a non-apoptotic mode of programmed cell death, is characterized by the disintegration of the plasma membrane, ultimately leading to cell perforation and rupture. Recent studies have disclosed the mechanism of necroptosis and its intimate link with nanomaterials. Nanomedicine represents a novel approach in the development of therapeutic agents utilizing nanomaterials to treat a range of cancers with high efficacy. This article provides an overview of the primary mechanism behind necroptosis, the current research progress in nanomaterials, their potential use in various diseases—notably cancer, safety precautions, and prospects. The goal is to aid in the development of nanomaterials for cancer treatment.
- 29 April 2025
- Published by Springer Nature in Cell Death Discovery
- Vol. 11 (1) , 1-11
Open AccessExploring necroptosis: mechanistic analysis and antitumor potential of nanomaterials
Necroptosis, a non-apoptotic mode of programmed cell death, is characterized by the disintegration of the plasma membrane, ultimately leading to cell perforation and rupture. Recent studies have disclosed the mechanism of necroptosis and its intimate link with nanomaterials. Nanomedicine represents a novel approach in the development of therapeutic agents utilizing nanomaterials to treat a range of cancers with high efficacy. This article provides an overview of the primary mechanism behind necroptosis, the current research progress in nanomaterials, their potential use in various diseases—notably cancer, safety precautions, and prospects. The goal is to aid in the development of nanomaterials for cancer treatment.
- Top Cited PapersOpen Access
- 29 April 2024
- Published by Springer Nature in Cell Death Discovery
- Vol. 10 (1) , 1-14
RIPK3 signaling and its role in regulated cell death and diseases
Receptor-interacting protein kinase 3 (RIPK3), a member of the receptor-interacting protein kinase (RIPK) family with serine/threonine protein kinase activity, interacts with RIPK1 to generate necrosomes, which trigger caspase-independent programmed necrosis. As a vital component of necrosomes, RIPK3 plays an indispensable role in necroptosis, which is crucial for human life and health. In addition, RIPK3 participates in the pathological process of several infections, aseptic inflammatory diseases, and tumors (including tumor-promoting and -suppressive activities) by regulating autophagy, cell proliferation, and the metabolism and production of chemokines/cytokines. This review summarizes the recent research progress of the regulators of the RIPK3 signaling pathway and discusses the potential role of RIPK3/necroptosis in the aetiopathogenesis of various diseases. An in-depth understanding of the mechanisms and functions of RIPK3 may facilitate the development of novel therapeutic strategies.
- 29 April 2024
- Published by Springer Nature in Cell Death Discovery
- Vol. 10 (1) , 1-14
Top Cited PapersOpen AccessRIPK3 signaling and its role in regulated cell death and diseases
Receptor-interacting protein kinase 3 (RIPK3), a member of the receptor-interacting protein kinase (RIPK) family with serine/threonine protein kinase activity, interacts with RIPK1 to generate necrosomes, which trigger caspase-independent programmed necrosis. As a vital component of necrosomes, RIPK3 plays an indispensable role in necroptosis, which is crucial for human life and health. In addition, RIPK3 participates in the pathological process of several infections, aseptic inflammatory diseases, and tumors (including tumor-promoting and -suppressive activities) by regulating autophagy, cell proliferation, and the metabolism and production of chemokines/cytokines. This review summarizes the recent research progress of the regulators of the RIPK3 signaling pathway and discusses the potential role of RIPK3/necroptosis in the aetiopathogenesis of various diseases. An in-depth understanding of the mechanisms and functions of RIPK3 may facilitate the development of novel therapeutic strategies.